Insulin strategy showdown: which approach keeps DKA patients out of the ICU longer?

NCT ID NCT07423559

First seen Feb 28, 2026 · Last updated May 14, 2026 · Updated 8 times

Summary

This study looked at 100 adults with type 1 diabetes who had diabetic ketoacidosis (DKA), a serious condition where blood sugar gets dangerously high. Researchers compared two ways of giving insulin: one group got a combination of long-acting (basal) insulin plus a continuous IV drip, while the other group only got the IV drip. The goal was to see which approach helped patients leave the ICU faster and reduced the chance of DKA coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Tanta University

    Tanta, Egypt

Conditions

Explore the condition pages connected to this study.